Manipal Health Enterprises’ ₹9,275.22 crore IPO entered its second day of subscription today, July 30, 2026, with a price band of ₹560 to ₹590 per share. As of 10:00 AM on Day 2, the IPO had been subscribed 0.16 times.
The IPO will remain open for subscription until July 31, 2026. The basis of allotment is expected to be finalised on August 3, 2026, while the shares are tentatively scheduled to be listed on the NSE and BSE on August 5, 2026.
The expected IPO schedule is as follows:
|
Event |
Date |
|
Subscription Opening Date |
29 July 2026 |
|
Subscription Closing Date |
31 July 2026 |
|
Basis of Allotment Date |
3 August 2026 |
|
Refund Initiation Date |
4 August 2026 |
|
Credit of Shares |
4 August 2026 |
|
Listing on BSE and NSE |
5 August 2026 |
Note: The allotment and listing dates are tentative and may be revised.
Explore other Upcoming IPOs on BSE and NSE.
The company intends to utilise the net proceeds from the fresh issue towards:
Explore other Upcoming IPOs on BSE and NSE.
[July 30, 2026, 10:00 AM]
|
Category |
Subscription (x) |
|
Qualified Institutional Buyers (QIBs) |
0.14x |
|
Non-Institutional Investors (NIIs) |
0.09x |
|
Retail Individual Investors (RIIs) |
0.31x |
|
Employees |
1.02x |
|
Total |
0.16x |
Manipal Health Enterprises is one of India's largest multispecialty hospital networks, operating 49 hospitals with 13,037 licensed beds across 14 states and union territories as of March 31, 2026. The company is the country's largest private hospital chain by bed capacity and the second largest by number of hospitals. During Fiscal 2026, it treated 7.63 million patients and had a network of 11,064 doctors.
The company focuses on tertiary and quaternary healthcare services, with specialties including cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics, and renal sciences (CONGO-R), which together accounted for 64.3% of its gross inpatient revenue in Fiscal 2026. Manipal Health has expanded its footprint through acquisitions such as AMRI Hospitals, Medica Synergie, and the Sahyadri Group, and aims to increase its capacity by adding around 2,426 licensed beds by 2030.
|
Particulars |
FY26 (in ₹ crore) |
FY25 (in ₹ crore) |
FY24 (in ₹ crore) |
|
Revenue from operations |
10,335.75 |
8,242.25 |
6,171.63 |
|
EBITDA |
2,795.94 |
2,247.07 |
1,776.60 |
|
Profit After Tax |
916.52 |
1,081.67 |
533.20 |
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here